These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1436854)

  • 21. Primary hyperparathyroidism in an elderly woman: surgical reversibility of profound mental state problems due to mild hypercalcaemia.
    Ann McDonald C; Bruce DG; Smith DJ
    Int J Geriatr Psychiatry; 2002 Jul; 17(7):601-3. PubMed ID: 12112155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of disodium pamidronate in children with hypercalcemia awaiting liver transplantation.
    Attard TM; Dhawan A; Kaufman SS; Collier DS; Langnas AN
    Pediatr Transplant; 1998 May; 2(2):157-9. PubMed ID: 10082449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe infantile hypercalcemia associated with Williams syndrome successfully treated with intravenously administered pamidronate.
    Cagle AP; Waguespack SG; Buckingham BA; Shankar RR; Dimeglio LA
    Pediatrics; 2004 Oct; 114(4):1091-5. PubMed ID: 15466114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous pamidronate sodium therapy in immobilization-related hypercalcemia.
    Tamion F; Bonmarchand F; Girault C; Chevron V; Leroy J
    Clin Nephrol; 1995 Feb; 43(2):138-9. PubMed ID: 7736680
    [No Abstract]   [Full Text] [Related]  

  • 25. Disodium pamidronate for treating severe hypercalcemia in a hemodialysis patient.
    Trimarchi H; Lombi F; Forrester M; Elizondo C; Sawinski D; Pereyra H; Freixas E
    Nat Clin Pract Nephrol; 2006 Aug; 2(8):459-63; quiz 464. PubMed ID: 16932480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of bisphosphonates for resistant hypercalcemia in children with acute lymphoblastic leukemia: report of two cases and review of the literature.
    Andiran N; Alikaşifoğlu A; Küpeli S; Yetgin S
    Turk J Pediatr; 2006; 48(3):248-52. PubMed ID: 17172070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
    Gibbs CJ; Peacock M
    Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abdominal symptoms, hypercalcaemia and apathetic hyperthyroidism: treatment with pamidronate.
    Ghose RR; Palmer DJ; Yaqoob M; Haboubi N; Ratcliffe WA
    Br J Clin Pract; 1994; 48(3):163-4. PubMed ID: 8031697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of immobilisation hypercalcaemia in acute intermittent porphyria: experience from three cases.
    Reading PJ; Newman PK; Kelly WF; Bateson MC; Rothwell P
    J Neurol Neurosurg Psychiatry; 1997 Apr; 62(4):421-2. PubMed ID: 9120470
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment of hypercalcaemia in thyrotoxicosis with aminohydroxypropylidene diphosphonate.
    Tan TT; Alzaid AA; Sutcliffe N; Gardner MD; Thomson JA; Boyle IT
    Postgrad Med J; 1988 Mar; 64(749):224-7. PubMed ID: 3174541
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A single bisphosphonate infusion is associated with improved functional capacity in elderly subjects with primary hyperparathyroidism.
    Ammann P; Herter-Clavel C; Lubrano A; Rizzoli R
    Aging Clin Exp Res; 2003 Dec; 15(6):500-4. PubMed ID: 14959954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercalcaemia in primary oxalosis: role of increased bone resorption and effects of treatment with pamidronate.
    Yamaguchi K; Grant J; Noble-Jamieson G; Jamieson N; Barnes ND; Compston JE
    Bone; 1995 Jan; 16(1):61-7. PubMed ID: 7742085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
    Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
    Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bisphosphonates and primary hyperparathyroidism.
    Rodan GA
    J Bone Miner Res; 2002 Nov; 17 Suppl 2():N150-3. PubMed ID: 12412793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to treat tumor-induced hypercalcemia].
    Body JJ
    Rev Prat; 2003 Dec; 53(19):2128-35. PubMed ID: 15008469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe immobilization-induced hypercalcemia in a child after liver transplantation successfully treated with pamidronate.
    Profumo RJ; Reese JC; Foy TM; Garibaldi LR; Kane RE
    Transplantation; 1994 Jan; 57(2):301-3. PubMed ID: 8310527
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic hypercalcemia as a reversible cause of cognitive impairment: improvement after a single administration of pamidronate.
    Duque G; Segal R; Wise F; Bianco J
    J Am Geriatr Soc; 2005 Sep; 53(9):1633-4. PubMed ID: 16137304
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of pamidronate in patients with renal failure and hypercalcemia.
    Machado CE; Flombaum CD
    Clin Nephrol; 1996 Mar; 45(3):175-9. PubMed ID: 8706358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.
    Coleman RE
    Oncology (Williston Park); 1991 Aug; 5(8):55-60; discussion 60-2, 65. PubMed ID: 1834153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.